We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HITI:NASDAQHigh Tide Inc. Analysis

Data as of 2026-05-29 - not real-time

$2.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

High Tide Inc. is trading at $2.495, modestly above its DCF‑derived fair value of $2.30, while the 20‑day SMA ($2.43) and 50‑day SMA ($2.39) sit just below the current price, indicating slight upward momentum. Technical indicators are mixed: the MACD line is bullish (0.006 vs signal 0.001), RSI is neutral at 56, and the stock hovers between a support of $2.315 and resistance of $2.590, suggesting limited upside in the near term. Fundamentally, the company reports strong top‑line growth (25% YoY revenue increase) and a record 7.6 tonnes of medical cannabis distributed in Germany, yet it remains unprofitable with a –7.4% net margin, negative EPS, and a high debt‑to‑equity ratio exceeding 110%.
Recent insider buying (≈90,000 shares) and the rollout of new Canna Cabana locations (now 221 stores) provide a positive catalyst, but the sector’s regulatory environment and the company’s cash‑flow constraints keep risk elevated. The “Extreme Greed” sentiment index (94) reflects market optimism, but volatility remains high at ~47% over 30 days, and the beta of ~0.91 signals price movements roughly in line with the broader market.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and insider share purchases
  • Price near technical support with limited upside to resistance
  • Persistent negative earnings and high leverage

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and record German distribution volumes
  • Expansion of Canna Cabana retail footprint
  • Improving top‑line trends despite current profitability challenges

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term industry growth potential in cannabis and hemp markets
  • Need to achieve sustainable profitability and reduce debt
  • Elevated sector and regulatory risks that could impact earnings

Key Metrics & Analysis

Financial Health

Revenue Growth25.20%
Profit Margin-7.42%
P/E Ratio17.6
ROE-39.72%
ROA3.87%
Debt/Equity110.31
P/B Ratio3.4
Op. Cash Flow$29.0M
Free Cash Flow$7.7M
Industry P/E27.5

Technical Analysis

TrendNeutral
RSI56.2
Support$2.32
Resistance$2.59
MA 20$2.43
MA 50$2.39
MA 200$2.77
MACDBullish
VolumeStable
Fear & Greed Index94.09

Valuation

Fair Value$2.30
Target Price$5.67
Upside/Downside127.12%
GradeFair
TypeBlend

Risk Assessment

Beta0.91
Volatility47.35%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.